| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Care Health Insurance Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Source of Funds |
|
|
|
Share Capital |
97,418 |
97,204 |
|
Reserves and Surplus |
1,35,702 |
1,19,778 |
|
Fair value change account - Shareholders |
2,791 |
2,250 |
|
Fair value change account - Policyholders |
1,304 |
542 |
|
Total Funds |
2,37,215 |
2,19,774 |
|
Application of Funds |
|
|
|
Investments - Shareholders |
2,46,633 |
2,13,035 |
|
Investments - Policyholders |
5,93,311 |
4,50,257 |
|
Fixed Assets |
3,385 |
4,190 |
|
Deferred Tax Asset (Net) |
4,402 |
4,123 |
|
Current Assets |
|
|
|
Cash and Bank Balances |
19,346 |
9,584 |
|
Advances and Other Assets |
35,012 |
30,108 |
|
Sub Total |
54,358 |
39,692 |
|
Current Liabilities |
3,34,310 |
2,00,256 |
|
Provisions |
3,30,564 |
2,91,267 |
|
Sub Total |
6,64,874 |
4,91,523 |
|
Net Current Assets |
-6,10,516 |
-4,51,831 |
|
Total Application of funds |
2,37,215 |
2,19,774 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Operating Profit/Loss |
|
|
|
Miscellaneous Insurance |
4,871 |
35,600 |
|
Income from Investments |
|
|
|
Interest, Dividend & Rent – Gross |
16,311 |
13,925 |
|
Profit on sale of investments |
1,681 |
825 |
|
(Loss on sale/redemption of investments) |
-308 |
-10 |
|
Amortisation of premium/discount on investments |
-422 |
-452 |
|
Other Income |
|
|
|
Bad debts recovered |
196 |
- |
|
Total |
22,329 |
49,888 |
|
Other Expenses |
|
|
|
Expenses other than Insurance Business |
50 |
80 |
|
Bad debts written off |
127 |
60 |
|
Expenses towards CSR activities |
502 |
279 |
|
Penalties |
1 |
1 |
|
Remuneration of MD/CEO/WTD/Other KMPs |
913 |
358 |
|
Foreign Exchange Loss/(Gain) |
-84 |
23 |
|
Total Expenses |
1,509 |
8,882 |
|
Profit / (Loss) Before Tax |
20,820 |
41,006 |
|
Current tax |
5,681 |
9,740 |
|
Tax related to Earlier years |
-100 |
219 |
|
Deferred tax (credit) |
-279 |
558 |
|
Profit After Tax |
15,518 |
30,489 |
|
Balance of profit brought forward from last year |
46,891 |
16,402 |
|
Balance carried forward to Balance sheet |
62,409 |
46,891 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash Flow from Operating Activities |
|
|
|
Premium received from policyholders |
10,74,542 |
8,21,490 |
|
Payments to re-insurers (net) |
13,378 |
16,109 |
|
Payments to co-insurers (net) |
738 |
-1,140 |
|
Payments of claims |
-4,90,620 |
-3,46,252 |
|
Commission and brokerage |
-1,86,540 |
-1,42,818 |
|
Other operating expenses |
-1,61,836 |
-1,43,155 |
|
Deposits, advances and staff loans |
-1,210 |
-530 |
|
Income taxes paid (Net) |
-5,040 |
-11,731 |
|
Service tax / GST paid |
-1,05,715 |
-87,126 |
|
Net cash from Operating activities |
1,37,697 |
1,04,847 |
|
Cash Flow from Investing Activities |
|
|
|
Purchase of fixed assets (including capital advances) |
-1,561 |
-1,323 |
|
Proceeds from sale of fixed assets |
17 |
16 |
|
Purchases of investments |
-2,36,178 |
-1,95,598 |
|
Sales of investments |
7,331 |
5,734 |
|
Repayments received |
47,090 |
43,288 |
|
Rents/Interests/ Dividends received |
49,308 |
37,955 |
|
Investments in money market instruments and in liquid mutual funds |
5,354 |
-6,867 |
|
Net cash from Investing activities |
-1,28,639 |
-1,16,795 |
|
Cash Flow from Financing Activities |
|
|
|
Proceeds from issuance of share capital |
620 |
11,575 |
|
Net cash from Financing activities |
620 |
11,575 |
|
Effect of Foreign exchange rates on cash & cash equivalents |
84 |
-24 |
|
Net increase in cash and cash equivalents |
9,762 |
-397 |
|
Cash & cash equivalents at year start |
9,584 |
9,981 |
|
Cash & cash equivalents at year end |
19,346 |
9,584 |
Here is a summary of the Cash Flow
Statement for the years 2025 and 2024:
Cash Flow from
Operating Activities
In FY 2025, the
company generated ₹1,37,697 lakhs of net cash from its
core insurance business operations, up from ₹1,04,847 lakhs in FY 2024. This
improvement reflects higher premium collections,
which rose from ₹8,21,490 lakhs to ₹10,74,542 lakhs — a strong 30%+ increase.
This shows the company is growing and acquiring more policyholders.
Major outgoing
payments include:
Claims
paid
(₹4,90,620 lakhs in FY25 vs ₹3,46,252 lakhs in FY24),
Commissions
and brokerage (₹1,86,540 lakhs vs ₹1,42,818 lakhs), and
Operating
expenses (₹1,61,836 lakhs vs ₹1,43,155 lakhs).
Taxes and GST
outflows were also significant, totaling over ₹1.1 lakh lakhs in FY25. Despite
these, strong premium inflow allowed for positive and growing net
operating cash.
Cash Flow from
Investing Activities
Investing cash flow
was negative
in both years, indicating the company is putting money into long-term
investments — which is expected for an insurance business.
In FY 2025, net cash
used was ₹1,28,639
lakhs, slightly better than FY 2024’s ₹1,16,795 lakhs.
Major outflows were
for purchase
of investments (₹2,36,178 lakhs in FY25), and fixed
assets (₹1,561 lakhs).
Cash inflows came
from:
Sale
of investments (₹7,331 lakhs),
Repayments
received (₹47,090 lakhs),
Investment
income (₹49,308 lakhs),
Liquid
fund investment redemption (₹5,354 lakhs).
This reflects a
well-managed investment portfolio where the company continually reallocates
funds to optimize returns, a key part of insurance company operations.
Cash Flow from
Financing Activities
Financing activities
were minimal in FY 2025 compared to FY 2024:
FY 2025 saw a small
inflow of ₹620 lakhs from issuance of share capital.
In FY 2024, this was
significantly higher at ₹11,575 lakhs,
indicating the company likely raised equity to strengthen its balance sheet
that year.
There were no
repayments of debt or interest payments, suggesting the company
is not reliant on borrowings for capital.
Effect of Foreign
Exchange Fluctuations
A minor gain
of ₹84 lakhs was recorded in FY 2025 due to foreign exchange
rate movements (compared to a loss of ₹24 lakhs in
FY 2024). While not a major factor, it positively impacted the final cash
position.
Net Change in
Cash Position
FY 2025: The
company saw a net increase of ₹9,762 lakhs in cash and
cash equivalents, largely due to robust operating cash inflows.
FY
2024:
There was a net cash decrease of ₹397 lakhs, showing
a tighter cash situation the previous year.
The closing cash
balance rose from ₹9,584 lakhs to ₹19,346 lakhs, more than
doubling — a healthy sign that the company is now in a stronger liquidity
position.
